← FDA Drug Approvals (Drugs@FDA)

BRIELLYN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2011-03-22

Drug application

FDA Application #

ANDA090538

Application type

Abbreviated New Drug Application (Generic)

Brand name

BRIELLYN

Generic name

NORETHINDRONE AND ETHINYL ESTRADIOL

Active ingredients

ETHINYL ESTRADIOL; NORETHINDRONE

Dosage form

TABLET

Route

ORAL-28

Marketing status

Prescription

Sponsor

GLENMARK PHARMS LTD

Manufacturer

Glenmark Pharmaceuticals Inc., USA

First approval

2011-03-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown